The market size for Connected Drug Delivery Devices was USD 20.64 Billion in 2022 and is expected to grow rapidly with a CAGR of 8% during the forecast period. The market growth is driven by the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, increased need for self-administration and home healthcare equipment, technological advancements, and rising demand for biologics and biosimilars.

The demand for patient-centric Connected Drug Delivery Devices is also increasing, driven by the need for patient convenience and comfort. The use of needle-free drug administration methods is increasing to reduce the risk of needlestick injuries and to improve patient compliance. The high cost of drug delivery systems, lack of reimbursement policies in developing countries, and strict regulatory criteria for approval are factors that could restrain market growth.

Get a sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/6242

The global Connected Drug Delivery Devices market is segmented into injectors, inhalers, pumps, transdermal patches, and others based on product type. The injectors market accounted for the largest revenue share in 2022 due to the increasing prevalence of chronic diseases, such as diabetes and cancer. The inhalers segment is expected to register steady growth due to the rising prevalence of respiratory conditions such as asthma, COPD, and cystic fibrosis. The pumps segment is expected to account for a significantly large revenue share due to the increasing use of pumps in various therapeutic fields, including oncology, pain treatment, and diabetes.

Based on end-use, the global Connected Drug Delivery Devices market is segmented into hospitals, home care, ASCs, and others. The hospitals segment is expected to grow the fastest due to the increasing prevalence of chronic diseases and rising demand for cutting-edge drug delivery systems. The home care segment is expected to account for a significantly large revenue share due to the increasing elderly population, prevalence of chronic diseases, and rising trend of self-administration of medications. The ASCs segment is also expected to register steady growth due to the increasing adoption of minimally invasive surgical procedures.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/6242

Key companies in the Connected Drug Delivery Devices market –

There are several key companies operating in the Connected Drug Delivery Devices market, including:

• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Bayer AG
• Roche Holding AG
• GlaxoSmithKline plc
• Medtronic plc
• Becton, Dickinson and Company
• 3M Company
• Cipla Inc.

The U.S. FDA, HHS, and WHO have established guidelines and international standards for Connected Drug Delivery Devices, which require manufacturers to meet minimum safety and efficacy standards. The FDA reviews new Connected Drug Delivery Devices for safety and efficacy, while the HHS provides subsidies and incentives to encourage the development of innovative Connected Drug Delivery Devices. WHO monitors the quality of drugs delivered through these devices.

In conclusion, the global Connected Drug Delivery Devices market is expected to grow rapidly during the forecast period, driven by the increasing prevalence of chronic diseases, rising demand for biologics and biosimilars, and the need for patient-centric Connected Drug Delivery Devices. The market is segmented based on product type and end-use, with injectors, inhalers, and pumps expected to account for significant revenue shares. The regulatory guidelines and international standards established by the FDA, HHS, and WHO ensure the safety and efficacy of Connected Drug Delivery Devices.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/6242

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs